You are here

Article Text

Article menu
Download PDFPDF
Review series
Exacerbations in cystic fibrosis: 3 · Management
  1. A Smyth1,
  2. J S Elborn2
  1. 1
    Department of Child Health, University of Nottingham and Department of Paediatric Respiratory Medicine, Nottingham City Hospital, Nottingham, UK
  2. 2
    Department of Respiratory Medicine, Queen’s University and Belfast City Hospital, Belfast, UK
  1. Professor J S Elborn, Adult Cystic Fibrosis Centre, Level 11, Belfast City Hospital, Belfast BT9 7AB, UK; stuart.elborn{at}bch.n-i.nhs.uk

Abstract

Exacerbations of pulmonary symptoms in patients with cystic fibrosis must be recognised early and treated vigorously in order to maintain pulmonary function and relieve symptoms. The aetiology of these exacerbations is discussed, together with the options for treatment and the evidence to support treatment choices.

https://doi.org/10.1136/thx.2006.060905

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Funding: None.

    • Competing interests: AS has received research funding from Forest Laboratories and has provided consultancy advice to Profile Pharma.